Suicide and psychotropic agents;Suicide et psychotropes

Encephale

Volumn 22, Issue SPEC. ISS. 4, 1996, Pages 40-45

  Lejoyeux, M ^a   Rouillon, F ^b  

^a BICHAT HOSPITAL   (France)

^b HÔPITAL LOUIS MOURIER   (France)

Author keywords

antidepressants; suicide; suicide attempts

Indexed keywords

ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; NEUROLEPTIC AGENT;

CONFERENCE PAPER; DEPRESSION; DRUG OVERDOSE; FRANCE; HUMAN; PRESCRIPTION; SUICIDE;

ANTIDEPRESSIVE AGENTS; CAUSE OF DEATH; DEPRESSIVE DISORDER; HUMANS; OVERDOSE; PSYCHOTROPIC DRUGS; RISK FACTORS; SUICIDE;

EID: 0030485614     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (34)

1. AVERY D, WINOKUR G. Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch Gen Psychiatry 1976 ; 33 : 1029-37.
2. BARRACLOUGH B, BUNCH J, NELSON B, SAINSBURY P. A hundred cases of suicide : clinical aspects. Brit J Psychiatry 1974 ; 125 : 355-73.
3. BEAUMONT G. The toxicity of antidepressants Brit J Psychiatry 1989 ; 154 : 457-8.
4. BESKOW J. Suicide and mental disorder in Swedish men. Acta Psychiatr Scandinavica 1979 ; supp 277 : 1-138.
5. CASSIDY S, HENRY J. Fatal toxicity of antidepressant drugs in overdose. BJM 1987 ; 295 : 1021-4.
6. DELAY J, DENIKER P, LEMPÉRIÈRE T, GINESTET D. Deux années d'expérience de l'imipramine. Ann Médico Psychol 1961 ; 235-48.
7. DUNBAR GC, MEWETT S. A double-blind comparative multicentric study of paroxetine and placebo in preventing recourent major depressive episodes. Br Psychopharmacol Association 21, 24/7/91, York.
8. FARMER RDT. Assessing the epidemiology of suicide and parasuicide. Br J Psychiatry 1988 ; 153 : 16-20.
9. GLEN AIM, JOHNSON AL, SHEPHERD M. Continuation therapy with lithium and amitriptyline in unipolar depressive illness : a randomized double blind controlled trial. Psychol Med 1984 ; 14 : 37-50.
10. GUZE SB, ROBINS E. Suicide and primary affective disorders. Br J Psychiatry 1970 ; 117 : 437-8.
11. HAGNELL O, LANKE J, RORSMAN B, OJESO L. Are we entering an age of melancholy ? Depressive illness in a prospective epidemiological study over 25 years. The Lundby Study Sweden. Psychol Medicine 1982 ; 12 : 279-89.
12. HENON M. Mélancolie (mémento clinique) Paris : Ed. techniques, Encyclopédie Médico Chirurgicale, Psychiatrie, 37210, A10, 1962 : 6 p.
13. ISACCSON G, WASSERMAN D, HOLMGREN P, BERGMAN U. Use of antidepressants among people committing suicide in Sweden. BMJ 1994 ; 308 : 506-9.
14. ISACSSON G, BERGMAN U, RICH CL. Antidepressants, depression and suicide : an analysis of the San Diego study. J Affect Disorders 1994 ; 32 : 277-86.
15. KAY DWK, FAHY T, GARSIDE RF. A seven month double blind trial of amitriptyline and diazepam in ECT treated depressed patients. Br J Psychiatry 1970 ; 117 : 667-71.
16. LECOMTE D, HATTON F, JOUGLA E, LE TOULLEC A. Le suicide à Paris et en Ile-de-France. Encéphale 1995 ; 21 : 41-9.
17. LEJOYEUX M, LÉON E, BOUILLON F. Prévalence et facteurs de risque du suicide et des tentatives de suicide. Encéphale 1994 ; 20 : 495-503.
18. MODESTIN J. Antidepressive therapy in depressed clinical suicides. Acta Psychiatr Scand 1985 ; 71 : 111-6.
19. MONTASSUT M, CHERTOK L, GACHKEL V, FERAN-JARAME. Essai d'interprétation clinique de l'action de l'imipramine. Ann Med Psychol 1959 ; 2/2 : 288-99.
20. MONTGOMERY SA, PINDER RM. Do some antidepressants promote suicide ? Psychopharmacology 1987 ; 92 : 265-6.
21. MURPHY CE, WOODRUFF RA, HERJANIC M. Variability of the clinical course of primary affective disorder. Arch Gen Psychiatry 1974 ; 30 : 757-61.
22. MURPHY GE. The physician's responsability for suicide. An error of commission. Ann Intern Med 1975 ; 82 : 301-4.
23. OHBERG A, LONNQVIST J, SARNA S, VUORI E, PENTTILA A. Trends and availibility of suicide methods in Finland. Proposal for restrictive measures. Brit J Psychiatry 1995 ; 166 : 35-43.
24. OSSELTON MD, BLACKMORE RC, KING LA, MOFFAT AC. Poisoning-associated deaths for England and Wales between 1973 and 1980. Human Toxicol 1984 ; 3 : 201-21.
25. PINDER RM. The benefits and risks of antidepressant drugs. Hum Psychopharmacol 1988 ; 3 : 73-86.
26. PRIEN R, KLETT CJ, CAFFEY EM. Lithium carbonate and imipramine in the prevention of affective episodes. Arch Gen Psychiatry 1973 ; 29 : 420-5.
27. ROUILLON F, PHILIPPS R, SERRURIER D, ANSART E, GERARD MJ. Efficacité préventive de la maprotiline sur les rechutes de la dépression unipolaire. Encéphale 1989 ; 15 : 527-34.
28. ROUILLON F, LEJOYEUX M, FILTEAU MJ. Unwanted effects of long-term treatment In Long Term Treatment of depression. Montgomery SA, Rouillon F edit. 1992. John Wiley and Sons Ltd, p. 83-111.
29. ROUILLON F, THALASSINOS M. Suicide, dépression et antidépresseurs. Ann Psychiatr 1993 ; 8 : 158-65.
30. ROY A. Risk factors for suicide in psychiatric patients. Arch Gen Psychiatry 1982 ; 39 : 1089-95.
31. ROY A. Suicide in recurrent affective disorder patients. Can J Psychiatry 1984 ; 29 : 319-22.
32. SEAGER CP, BIRD RI. Imipramine with electrical treatment in depression : a controlled trial. J Ment Sci 1962 ; 108 : 704-7.
33. TEICHER MH, GLOD C, COLE JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 1990 ; 147 : 207-10.
34. TIGNOL J, BOURGEOIS M. La désinhibition et ses risques. Encéphale 1978 ; 4 : 459-63.